No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia-Reference-Cited by-同舟云学术

No cognitive-enhancing effect of GLP-1 receptor agonism in antipsychotic-treated, obese patients with schizophrenia

Published:2017-03-05 Issue:1 Volume:136 Page:52-62
ISSN:0001-690X
Container-title:Acta Psychiatrica Scandinavica
language:en
Short-container-title:Acta Psychiatr Scand

Author:

Ishøy P. L.¹²,Fagerlund B.¹²,Broberg B. V.¹,Bak N.¹,Knop F. K.²³⁴,Glenthøj B. Y.¹²,Ebdrup B. H.¹^ORCID

Affiliation:

1. Center for Neuropsychiatric Schizophrenia Research, CNSR; Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS; Mental Health Centre Glostrup; University of Copenhagen; Glostrup Denmark

2. Department of Clinical Medicine; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

3. Center for Diabetes Research; Gentofte Hospital; University of Copenhagen; Hellerup Denmark

4. The Novo Nordisk Foundation Centre for Basic Metabolic Research; Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark

Funder

Københavns Universitet

University of Copenhagen/Mental Health Services, Capital Region of Denmark

Lundbeckfonden

Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research, CINS

Publisher

Wiley

Subject

Psychiatry and Mental health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/acps.12711/fullpdf

Reference54 articles.